Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Ludden

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
Clinical Pharmacokinetics|June 1, 1991
Nonlinear pharmacokinetics: clinical ImplicationsT M Ludden
The Journal of Pharmacy and Pharmacology|February 1, 1980
Individualization of phenytoin therapyT M Ludden
Journal of Clinical Pharmacology|December 1, 1988
Population pharmacokineticsT M Ludden
Clinical Pharmacokinetics|January 1, 1985
Pharmacokinetic interactions of the macrolide antibioticsT M Ludden
European Journal of Clinical Pharmacology|January 1, 1993
Bioavailability of controlled release carbamazepine estimated by mixed effect modellingR Miller, T M Ludden
American Journal of Hospital Pharmacy|September 1, 1978
Treatment of digoxin poisoningsD G Fraser, T M Ludden
Computers in Biology and Medicine|May 1, 1995
A spreadsheet program for simulation of bioequivalence and bioavailability studiesH Y Abdallah, T M Ludden
Pharmaceutical Research|December 1, 1995
Population pharmacokinetic modeling: the importance of informative graphicsE I Ette, T M Ludden
Annual Review of Pharmacology and Toxicology|January 1, 1992
Population pharmacokinetics/dynamicsL B Sheiner, T M Ludden
Biochemical Pharmacology|April 1, 1989
Exhaled alkanes as indices of in vivo lipid peroxidationR F Burk, T M Ludden
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Clinical Pharmacokinetics|June 1, 1991
Nonlinear pharmacokinetics: clinical ImplicationsT M Ludden
The Journal of Pharmacy and Pharmacology|February 1, 1980
Individualization of phenytoin therapyT M Ludden
Journal of Clinical Pharmacology|December 1, 1988
Population pharmacokineticsT M Ludden
Clinical Pharmacokinetics|January 1, 1985
Pharmacokinetic interactions of the macrolide antibioticsT M Ludden
European Journal of Clinical Pharmacology|January 1, 1993
Bioavailability of controlled release carbamazepine estimated by mixed effect modellingR Miller, T M Ludden
American Journal of Hospital Pharmacy|September 1, 1978
Treatment of digoxin poisoningsD G Fraser, T M Ludden
Computers in Biology and Medicine|May 1, 1995
A spreadsheet program for simulation of bioequivalence and bioavailability studiesH Y Abdallah, T M Ludden
Pharmaceutical Research|December 1, 1995
Population pharmacokinetic modeling: the importance of informative graphicsE I Ette, T M Ludden
Annual Review of Pharmacology and Toxicology|January 1, 1992
Population pharmacokinetics/dynamicsL B Sheiner, T M Ludden
Biochemical Pharmacology|April 1, 1989
Exhaled alkanes as indices of in vivo lipid peroxidationR F Burk, T M Ludden
Pageof 13